Bankrupt Savient Takes $120M Bid From Pharma Co. Crealta
Drug developer Savient Pharmaceuticals Inc. announced Tuesday it will sell the bulk of its assets to Crealta Pharmaceuticals LLC, which submitted a $120.4 million offer at the company's bankruptcy auction....To view the full article, register now.
Already a subscriber? Click here to view full article